Pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceutical companies ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 19:33 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- SEK 51.47T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | SEK 48B | SEK 136.81 | 3.17% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | SEK 96.1B | SEK 1,011.47 | 6.00% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | SEK 65.8B | SEK 969.46 | 1.05% down | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | SEK 53.3B | SEK 1,264.03 | 1.09% down | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | SEK 39.8B | SEK 290.81 | 2.69% down | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | SEK 75.8B | SEK 964.58 | 0.29% down | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | SEK 49B | SEK 870.59 | 1.60% down | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | SEK 101B | SEK 668.18 | 4.75% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | SEK 240B | SEK 209.38 | 0.66% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | SEK 283.2B | SEK 390.80 | 0.75% down | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | SEK 46.3B | SEK 422.84 | 1.12% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | SEK 77.3B | SEK 221.84 | 3.27% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | SEK 405.6B | SEK 705.35 | 0.97% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | SEK 500B | SEK 428.53 | 1.15% down | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | SEK 321.7B | SEK 521.70 | 1.29% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | SEK 87.2B | SEK 3,118.38 | 0.50% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | SEK 79.3B | SEK 471.76 | 2.05% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | SEK 691.5B | SEK 216.45 | 1.66% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | SEK 3.44T | SEK 1,396.72 | 4.22% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | SEK 83.3B | SEK 1,276.14 | 0.63% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | SEK 49.3B | SEK 513.72 | 1.16% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | SEK 60.9B | SEK 3,044.07 | 1.86% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | SEK 6.7T | SEK 2,782.00 | 1.86% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | SEK 160.5B | SEK 2,499.79 | 2.10% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | SEK 994.1B | SEK 9,609.68 | 1.36% down | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | SEK 12.54T | SEK 14,075.90 | 2.24% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | SEK 1.24T | SEK 606.23 | 2.85% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | SEK 64.7B | SEK 1,593.95 | 0.64% down | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | SEK 61.2B | SEK 937.32 | 0.22% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | SEK 180B | SEK 2,743.50 | 0.54% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | SEK 1.39T | SEK 5,467.57 | 0.62% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | SEK 5.13T | SEK 2,904.67 | 2.48% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | SEK 2.98T | SEK 1,577.42 | 2.55% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | SEK 250.8B | SEK 5,888.48 | 0.89% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | SEK 136.5B | SEK 273.11 | 3.87% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | SEK 153.8B | SEK 789.78 | 1.10% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | SEK 469.6B | SEK 4,110.88 | 2.20% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | SEK 1.63T | SEK 285.21 | 1.51% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | SEK 84.7B | SEK 1,221.72 | 3.00% up | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | SEK 120B | SEK 619.76 | 4.14% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | SEK 62.1B | SEK 439.57 | 0.52% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | SEK 991B | SEK 494.39 | 1.29% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | SEK 127.1B | SEK 152.42 | 1.32% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | SEK 2.82T | SEK 1,815.84 | 2.06% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | SEK 58.3B | SEK 85.66 | 2.42% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | SEK 1.15T | SEK 480.05 | 0.70% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | SEK 71.8B | SEK 1,365.14 | 1.28% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | SEK 75.3B | SEK 688.44 | 3.41% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | SEK 1.77T | SEK 400.71 | 3.21% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | SEK 1.84T | SEK 1,063.04 | 0.19% down | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | SEK 51B | SEK 610.30 | 0.60% down | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | SEK 72.5B | SEK 520.48 | 0.93% down | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | SEK 49.7B | SEK 285.72 | 0.86% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | SEK 94.9B | SEK 4,085.90 | 4.81% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | SEK 74.4B | SEK 849.84 | 1.77% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | SEK 352.9B | SEK 868.44 | 2.27% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | SEK 86B | SEK 107.51 | 0.94% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | SEK 268.1B | SEK 1,222.02 | 1.41% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | SEK 31.9B | SEK 164.37 | 0.31% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | SEK 46.8B | SEK 281.14 | 2.52% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | SEK 203.4B | SEK 1,518.83 | 4.59% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1717 SEK).
Questions and answers
Which pharmaceutical companies rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceutical companies ranked by one-year price change as of 18 Nov 2026, 19:33 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by one-year price change have a combined market value of SEK 51.47T as of 18 Nov 2026, 19:33 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.